Negoro Shunichi | Osaka Phase I Study Group
スポンサーリンク
概要
関連著者
-
Fukuoka Masahiro
Osaka Phase I Study Group
-
Minakuchi Kazuo
大阪府立呼吸器･アレルギー医療センター 肺腫瘍内科
-
Kudoh S
Osaka Phase I Study Group
-
Negoro Shunichi
Osaka Phase I Study Group
-
Matsui Kaoru
Department Of Thoracic Malignancy Osaka Prefectural Medical Center For Respiratory And Allergic Dise
-
Minakuchi Kazuo
Department Of Thoracic Malignancy Osaka Prefectural Medical Center For Respiratory And Allergic Dise
-
Masuda Noriyuki
The Second Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
KUSUNOKI Yoko
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
NAKAGAWA KAZUHIKO
Osaka Phase I Study Group
-
Kusunoki Yoko
2nd Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
MASUDA Noriyuki
Department of Respiratory Medicine, Kitasato University School of Medicine
-
Takada M
Osaka Prefectural Habikino Hospital Osaka Jpn
-
Masuda Noriyuki
Department Of Respiratory Disease Graduate School Of Medical Sciences Kitasato University
-
FUKUOKA Masahiro
Department of Respiratory Diseases, Osaka City General Hospital
-
KUSUNOKI Yoko
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
MATSUI Kaoru
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
NAKAGAWA Kazuhiko
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
TAKADA Minoru
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
Takada Minoru
Rinku General Medical Center
-
Takifuji Nobuhide
Medicine Osaka Municipal Momoyama Citizen's Hospital
-
Nakagawa Kazuhiko
Department Of Immunology Okayama University Graduate School Of Medicine And Dentistry
-
Kusunoki Yoko
Department Of Cancer Control And Statistics Osaka Medical Center For Cancer And Cardiovascular Disea
-
Fukuoka Masahiro
Department Of Cardiology National Sagamihara Hospital
-
Nakagawa Kazuhiko
Department Of Chemistry And Materials Technology Faculty Of Engineering And Design Kyoto Institute O
-
Takifuji Nobuhide
Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
Kudoh Sinzoh
Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
Negoro Shunichi
Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
YANA Takashi
the Second Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
Yana Takashi
The Second Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
Kubota Kaoru
Department Of Internal Medicine National Kinki Central Hospital
-
KUDOH Shinzoh
Department of Respiratory Medicine, Osaka City University Hospital
-
MATSUI Kaoru
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
MASUDA Noriyuki
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
UCHIDA Yasuo
Scientific Affairs Department, Pharmaceuticals Group. Nippon Kayaku Co., Ltd.,
-
FUKUOKA Masahiro
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
NEGORO Shunichi
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
YANA Takashi
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
KUDOH Shinzoh
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
KAWASE Ichiro
2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
KAWAHARA Masaaki
Department of Internal Medicine, National Kinki Central Hospital
-
OGAWARA Mitsumasa
Department of Internal Medicine, National Kinki Central Hospital
-
KODAMA Nagahisa
Department of Internal Medicine, National Kinki Central Hospital
-
FURUSE Kiyoyuki
Department of Internal Medicine, National Kinki Central Hospital
-
UEJIMA HISAO
Osaka Phase I Study Group
-
NEGORO SYUNICHI
Osaka Phase I Study Group
-
MATSUI KAORU
Osaka Phase I Study Group
-
KUDOH SHINZOU
Osaka Phase I Study Group
-
YOSHIKAWA Atsuko
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
NEGORO Shun-ichi
Medicine, Osaka Municipal Momoyama Citizen's Hospital
-
TAKIFUJI Nobuhide
Medicine, Osaka Municipal Momoyama Citizen's Hospital
-
HIRASHIMA Tomonori
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
YANA Takashi
Department of Internal Medicine, Osaka Prefectural Habikino Hospita
-
Imamura Sumitaka
Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
Fujisue Mamoru
Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
Fujisue Mamoru
Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
Ogawara Mitsumasa
Department Of Internal Medicine National Kinki Central Hospital
-
FURUSE Kiyoyuki
Osaka Central Hospital
-
Imamura Sumitaka
Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
Yoshikawa Atsuko
Department Of Internal Medicine Osaka Prefectural Habikino Hospita
-
Kobayashi Masashi
Tzt-1027 Cooperative Study Group
-
Hirashima Tomonori
Department Of Thoracic Malignancy Osaka Prefectural Medical Center For Respiratory And Allergic Dise
-
Kawase Ichiro
2nd Department Of Internal Medicine Osaka Prefectural Habikino Hospital
-
Uchida Yasuo
Scientific Affairs Department Pharmaceuticals Group. Nippon Kayaku Co. Ltd.
-
Kudoh Shinzoh
Department Of Respiratory Medicine Osaka City University Grasuate School Of Medicine
-
Kubota Kaoru
Department Of Cardiovascular Dynamics Research Institute National Cardiovascular Center
-
Furuse K
Osaka Central Hospital
-
Furuse Kiyoyuki
Department Of Internal Medicine National Kinki Central Hospital For Chest Diseases
-
Fukuoka Masahiro
Osaka City University Medical School
-
Kodama Nagahisa
Department Of Internal Medicine National Kinki Central Hospital
-
Kawahara Masaaki
Department Of Applied Chemistry Faculty Of Engineering Saitama Universtiy
-
Hirashima Tomonori
Department Of Thoracic Malignancy Osaka Prefectural Medical Center For Respiratory And Allergic Dise
著作論文
- Determinants of Myelosuppression in the Treatment of Non-small Cell Lung Cancer with Cisplatin-containing Chemotherapy
- Phase I and Pharmacokinetics Trial of BNP7787 in Patients Receiving Cisplatin and Paclitaxel
- Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin
- E-22 Establishment of Tumor Cell Lines as An Independent Prognostic Factor in Small Cell Lung Cancer (SCLC)
- 65 Seven Small Cell Lung Cancer (SCLC) Cell Lines established from Bronchofiberscope Biopsies